FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer

NCT01896869 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Adenocarcinoma

Interventions

DRUG: Ipilimumab
BIOLOGICAL: Vaccine
DRUG: FOLFIRINOX

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins